95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.89%
Positive revenue growth while FNV is negative. John Neff might see a notable competitive edge here.
-3.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.14%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.14%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3.92%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share reduction more than 1.5x FNV's 2.93%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.12%
Reduced diluted shares while FNV is at 2.89%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.56%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
5.81%
FCF growth under 50% of FNV's 653.10%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
513.84%
10Y revenue/share CAGR above 1.5x FNV's 74.53%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
204.35%
5Y revenue/share CAGR above 1.5x FNV's 74.53%. David Dodd would look for consistent product or market expansions fueling outperformance.
309.78%
3Y revenue/share CAGR above 1.5x FNV's 61.60%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4244.28%
10Y OCF/share CAGR above 1.5x FNV's 58.95%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
289.09%
5Y OCF/share CAGR above 1.5x FNV's 58.95%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
450.63%
3Y OCF/share CAGR above 1.5x FNV's 135.34%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
13671.58%
Net income/share CAGR above 1.5x FNV's 160.25% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
287.69%
5Y net income/share CAGR above 1.5x FNV's 160.25%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
546.07%
3Y net income/share CAGR above 1.5x FNV's 4.33%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2996.55%
10Y equity/share CAGR above 1.5x FNV's 38.47%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
139.38%
5Y equity/share CAGR above 1.5x FNV's 38.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
83.50%
3Y equity/share CAGR above 1.5x FNV's 21.08%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.66%
Firm’s AR is declining while FNV shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.70%
Asset growth above 1.5x FNV's 0.06%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.90%
Positive BV/share change while FNV is negative. John Neff sees a clear edge over a competitor losing equity.
-9.99%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.99%
We cut SG&A while FNV invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.